Distinct binding mode of I-125-AngII to AT(1) receptor without the Cys(18)-Cys(274) disulfide bridge

Autor(es)

Martin, Renan P. ^[1] ; Rodrigues, Eliete S. ^[1] ; Pacheco, Nelson A. S. ^[1] ; Correa, Silvana A. A. ^[1] ; Oliveira, Suzana M. ^[1] ; Oliveira, Laerte ^[1] ; Nakaie, Clovis R. ^[1] ; Shimuta, Suma I. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo, Dept Biophys, BR-04023062 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Regulatory Peptides; v. 158, n. 1-3, p. 14-18, NOV 27 2009.
• Citações Web of Science: 2

Resumo

Previous studies on angiotensin II (AngII) AT(1) receptor function have revealed that the N-terminal residues of AngII may modulate receptor activation by binding at the receptor extracellular site. A remarkable feature of this site is an insertion of 8 amino acids in the middle of the EC-3 loop including the Cys(274) residue that supposedly makes a disulfide bond with N-terminal Cys(18). As demonstrated by assays with Del(267-275)AT(1), the role of the Cys(18)-Cys(274) disulfide bridge is to keep a conformation of the inserted residues that allows a normal binding of the AngII N-terminal residues. C18S AT(1) receptor mutant, supposedly having a dissociated disulfide bridge, but an intact residue insertion, is constitutively activated and can less efficiently bind AngII. Similar results were observed when the S-S disulfide bond was disrupted in (C18S,C274S) AT(1) receptor. The importance of the free N-terminal amino group of Asp(1) and of the Arg(2) guanidino group for the binding of AngII to C18S mutant with EC-3 loop insertion was investigated by means of assays using AngII peptide analogues bearing a single mutation of Asp(1) for Sar(1) or Arg(2) for Lys(2), as ligands. This study showed that like AngII, {[}Sar(1)]-AngII can bind the C185 mutant receptor with low affinity whereas {[}Lys(2)]-AngII binding is still more reduced. Interestingly, when (125)I-AngII instead of (3)H-AngII was used, no significant binding of this mutant was observed although wild type AT, receptor was shown to bind all AngII analogues. (C) 2009 Elsevier B.V. All rights reserved. (AU)

• Processo FAPESP: 07/01910-0 - Identificação de diferentes modos de ligação do domínio N-terminal da Angiotensina II com receptores AT1 selvagem e mutantes
• Beneficiário: Renan Paulo Martin
• Modalidade de apoio: Bolsas no Brasil - Mestrado